Table 1.
Different studies or case reports on imatinib discontinuation
The total number corresponds to 298 patients.
NA indicates not applicable.
*Two patients had shown sustained MMR (<0.1%) for 98 months or near MMR (0.175%) for 24 months, respectively, with no therapy.
†Different criteria of molecular recurrence were used.